For NH Mantle Cell Lymphoma only present in the bone marrow, I had 4 frontline treatments of Bendamustine and Rituxin from Nov 2013-Feb 2014. I had only 4 maintenance treatments of Rituxin after that every 2 months. Maintenance was stopped due to issues with severe nuetrapenia which resulted in a staph infection in my blood and hospitalization. Doing well now, and white blood count is finally back to normal a year later.
However, I recently had a TIA and have been researching if these treatments could have put me at a higher risk for CVD. I found one article that indicated ac3 times higher risk, but that study was done on patients with Hodgkins Lymphoma. What information can you give me on this. Just a link would be fine.